摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-二(环己基甲基)脲 | 5472-16-2

中文名称
1,3-二(环己基甲基)脲
中文别名
——
英文名称
1,3-Bis(cyclohexylmethyl)urea
英文别名
1,3-bis-cyclohexylmethylurea;N,N'-di-cyclohexylmethyl urea;N,N'-bis-cyclohexylmethyl-urea;N,N'-Bis-cyclohexylmethyl-harnstoff
1,3-二(环己基甲基)脲化学式
CAS
5472-16-2
化学式
C15H28N2O
mdl
——
分子量
252.4
InChiKey
SVZORQBLCFZGBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    41.1
  • 氢给体数:
    2
  • 氢受体数:
    1

SDS

SDS:bd51b6a5f685a0a10bef460daf25bd35
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    8-substituted xanthine derivatives and method of use thereof
    摘要:
    一种用于治疗脑血管疾病和/或与脑衰老相关的疾病和/或其他疾病的方法,包括给予化合物(I)的有效、无毒量的给药,其中R.sup.1和R.sup.2各自独立地代表烷基或式(a)的基团:--(CH.sub.2).sub.m --A(a),其中m表示零或整数1、2或3;A表示取代或未取代的环烃基;R.sup.3表示卤原子、硝基基团或基团--NR.sup.4 R.sup.5,其中R.sup.4和R.sup.5各自独立地代表氢、烷基或烷基羰基,或R.sup.4和R.sup.5与它们连接的氮一起形成一个可选择取代的杂环基团;某些落入式(I)的新化合物和包含这些化合物的组合物。
    公开号:
    US05734051A1
  • 作为产物:
    描述:
    作用下, 以 氘代二甲亚砜氘代氯仿 为溶剂, 反应 36.0h, 生成 1,3-二(环己基甲基)脲
    参考文献:
    名称:
    Hydrolyzable Polyureas Bearing Hindered Urea Bonds
    摘要:
    Hydrolyzable polymers are widely used materials that have found numerous applications in biomedical, agricultural, plastic, and packaging industrials. They usually contain ester and other hydrolyzable bonds, such as anhydride, acetal, ketal, or imine, in their backbone structures. Here, we report the first design of hydrolyzable polyureas bearing dynamic hindered urea bonds (HUBs) that can reversibly dissociate to bulky amines and isocyanates, the latter of which can be further hydrolyzed by water, driving the equilibrium to facilitate the degradation of polyureas. Polyureas bearing 1-tert-butyl-1-ethylurea bonds that show high dynamicity (high bond dissociation rate), in the form of either linear polymers or cross-linked gels, can be completely degraded by water under mild conditions. Given the simplicity and low cost for the production of polyureas by simply mixing multifunctional bulky amines and isocyanates, the versatility of the structures, and the tunability of the degradation profiles of HUB-bearing polyureas, these materials are potentially of very broad applications.
    DOI:
    10.1021/ja5093437
点击查看最新优质反应信息

文献信息

  • Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disorders
    申请人:Glaxo Wellcome Inc.
    公开号:US06355646B1
    公开(公告)日:2002-03-12
    The present invention provides a compound of formula (I) or a solvate thereof wherein: X is —O— or —NH—; Q is (—CH2—)p, (—CH═CH—)p, (—C≡C—)p where p is an integer of from 0 to 4; R1 is hydrogen or methyl; R2 and R3 independently represent O or S n is an integer of 1 to 50; and R is hydrogen or methyl. The present invention also provides pharmaceutical compositions and methods of treatment using the compounds of formula (I). The compounds of the present invention are useful for the prophylaxis and treatment of septic shock, inflammatory conditions and immune disorders.
    本发明提供了以下式(I)的化合物或其溶剂结晶体,其中: X为—O—或—NH—; Q为(—CH2—)p,(—CH═CH—)p,(—C≡C—)p,其中p为0至4的整数; R1为氢或甲基; R2和R3独立地代表O或S; n为1至50的整数;以及 R为氢或甲基。 本发明还提供了使用上述式(I)化合物的药物组合物和治疗方法。本发明的化合物对于预防和治疗感染性休克、炎症性疾病和免疫紊乱非常有用。
  • Amine‐Responsive Disassembly of Au <sup>I</sup> –Cu <sup>I</sup> Double Salts for Oxidative Carbonylation
    作者:Yanwei Cao、Jian‐Gong Yang、Yi Deng、Shengchun Wang、Qi Liu、Chaoren Shen、Wei Lu、Chi‐Ming Che、Yong Chen、Lin He
    DOI:10.1002/anie.201914089
    日期:2020.1.27
    A sensitive amine-responsive disassembly of self-assembled AuI -CuI double salts was observed and its utilization for the synergistic catalysis was enlightened. Investigation of the disassembly of [Au(NHC)2 ][CuI2 ] revealed the contribution of Cu-assisted ligand exchange of N-heterocyclic carbene (NHC) by amine in [Au(NHC)2 ]+ and the capacity of [CuI2 ]- on the oxidative step. By integrating the
    观察到自组装的AuI-CuI复盐的敏感的胺反应分解,并启发了其在协同催化中的应用。对[Au(NHC)2] [CuI2]的分解研究表明,胺在[Au(NHC)2] +中的铜辅助配位交换了N-杂环卡宾(NHC)和[CuI2]的容量-在氧化步骤上。通过整合编码在d10金属配合物的响应行为和固有催化功能中的暗示信息,开发了一种用于胺的氧化羰基化的催化剂。该方法的优势已在温和的反应条件和明显扩大的范围上得到了明显体现(51个实例)。伯胺和空间仲胺都可以用作底物。金和铜中心的协同反应
  • Synthesis of polyamines via hydroaminomethylation of alkenes with urea—a new, effective and versatile route to dendrons and dendritic core molecules
    作者:Kai-Sven Müller、Fikret Koç、Stefan Ricken、Peter Eilbracht
    DOI:10.1039/b513348c
    日期:——
    Polyamines, structurally related to putrescines and spermidines, are easily obtainable via hydroaminomethylation of methylallylphthalimide with primary or secondary amines. In addition, hydroaminomethylation of monoolefins with urea as a synthetic equivalent for ammonia, in contrast to other methods (e.g. the alkylation of ammonia or ammonium salts), allows selective synthesis of symmetric tertiary
    在结构上与腐胺和亚精胺有关的多胺很容易通过甲基烯丙基邻苯二甲酰亚胺与伯胺或仲胺的加氢氨基甲基化反应而制得。此外,与其他方法(例如氨或铵盐的烷基化)相比,用尿素作为氨的合成等同物进行的单烯烃的氢氨基甲基化(例如氨或铵盐的烷基化)可以选择性地合成对称的叔胺。通过将两种方法结合,可方便地获得树枝状和树枝状聚合物核。
  • Methods of treating periodontal disease
    申请人:——
    公开号:US20030032804A1
    公开(公告)日:2003-02-13
    The present invention relates to novel compounds of formula (I): processes for their preparation, pharmaceutical formulations containing them, and their use in medicine, particularly in the prophylaxis and treatment of inflammatory conditions, immune disorders, septic shock circulatory disorders, and gastrointestinal inflammation and disorders.
    本发明涉及公式(I)的新化合物,其制备方法,含有它们的药物配方,以及它们在医学中的应用,特别是在预防和治疗炎症症状、免疫紊乱、感染性休克循环障碍以及胃肠道炎症和疾病方面的应用。
  • Phenylxanthine derivatives
    申请人:Glaxo Wellcome Inc.
    公开号:US05776940A1
    公开(公告)日:1998-07-07
    The present invention relates to novel compounds of formula (I), processes for their preparation, pharmaceutical formulations containing them, and their use in medicine, particularly in the prophylaxis and treatment of septic shock, allergic, and inflammatory conditions, as well as neurodegeneration.
    本发明涉及公式(I)的新化合物,其制备方法,含有它们的药物配方,以及它们在医学中的应用,特别是在预防和治疗感染性休克、过敏和炎症症状,以及神经退行性疾病方面的应用。
查看更多